The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-(3-(3-(1H-Imidazol-1-yl)propyl)ureido)-4-hydroxy-2-naphthoic Acid ID: ALA5205933
PubChem CID: 168295156
Max Phase: Preclinical
Molecular Formula: C18H18N4O4
Molecular Weight: 354.37
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(NCCCn1ccnc1)Nc1ccc2cc(C(=O)O)cc(O)c2c1
Standard InChI: InChI=1S/C18H18N4O4/c23-16-9-13(17(24)25)8-12-2-3-14(10-15(12)16)21-18(26)20-4-1-6-22-7-5-19-11-22/h2-3,5,7-11,23H,1,4,6H2,(H,24,25)(H2,20,21,26)
Standard InChI Key: QJXVNVOUCCZPEA-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
-3.1524 -1.5738 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.1524 -0.7488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4389 -0.3347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7235 -0.7456 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0099 -0.3315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2945 -0.7424 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.4189 -0.3284 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1344 -0.7393 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.8479 -0.3252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5633 -0.7361 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2768 -0.3221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9922 -0.7330 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.7451 -0.3958 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2985 -1.0076 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.8876 -1.7230 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0803 -1.5532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4189 0.4965 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.0099 0.4934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7271 0.9043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4389 0.4902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1560 0.9011 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8696 0.4870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5850 0.8980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5850 1.7230 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-5.2985 0.4839 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.8696 -0.3379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
2 3 1 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
13 12 1 0
14 13 2 0
15 14 1 0
16 12 1 0
16 15 2 0
7 17 2 0
5 18 1 0
18 19 2 0
20 19 1 0
3 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
23 25 1 0
22 26 1 0
26 2 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 354.37Molecular Weight (Monoisotopic): 354.1328AlogP: 2.65#Rotatable Bonds: 6Polar Surface Area: 116.48Molecular Species: ACIDHBA: 5HBD: 4#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: 3.76CX Basic pKa: 6.79CX LogP: 0.60CX LogD: -0.12Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.51Np Likeness Score: -1.25
References 1. Iannelli G, Milite C, Marechal N, Cura V, Bonnefond L, Troffer-Charlier N, Feoli A, Rescigno D, Wang Y, Cipriano A, Viviano M, Bedford MT, Cavarelli J, Castellano S, Sbardella G.. (2022) Turning Nonselective Inhibitors of Type I Protein Arginine Methyltransferases into Potent and Selective Inhibitors of Protein Arginine Methyltransferase 4 through a Deconstruction-Reconstruction and Fragment-Growing Approach., 65 (17.0): [PMID:35482954 ] [10.1021/acs.jmedchem.2c00252 ]